SG11202011240YA - Crispr/cas and transposase based amplification compositions, systems and methods - Google Patents
Crispr/cas and transposase based amplification compositions, systems and methodsInfo
- Publication number
- SG11202011240YA SG11202011240YA SG11202011240YA SG11202011240YA SG11202011240YA SG 11202011240Y A SG11202011240Y A SG 11202011240YA SG 11202011240Y A SG11202011240Y A SG 11202011240YA SG 11202011240Y A SG11202011240Y A SG 11202011240YA SG 11202011240Y A SG11202011240Y A SG 11202011240YA
- Authority
- SG
- Singapore
- Prior art keywords
- crispr
- cas
- systems
- methods
- based amplification
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/101—Temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/125—Specific component of sample, medium or buffer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/13—Plant traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862690160P | 2018-06-26 | 2018-06-26 | |
| US201862767077P | 2018-11-14 | 2018-11-14 | |
| PCT/US2019/039195 WO2020006049A1 (en) | 2018-06-26 | 2019-06-26 | Crispr/cas and transposase based amplification compositions, systems and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202011240YA true SG11202011240YA (en) | 2020-12-30 |
Family
ID=67263112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202011240YA SG11202011240YA (en) | 2018-06-26 | 2019-06-26 | Crispr/cas and transposase based amplification compositions, systems and methods |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12559786B2 (https=) |
| EP (1) | EP3814519A1 (https=) |
| JP (1) | JP2021528975A (https=) |
| KR (1) | KR20210024009A (https=) |
| CN (1) | CN112368396A (https=) |
| AU (1) | AU2019294690A1 (https=) |
| BR (1) | BR112020025319A2 (https=) |
| CA (1) | CA3101066A1 (https=) |
| MX (1) | MX2020013778A (https=) |
| SG (1) | SG11202011240YA (https=) |
| WO (1) | WO2020006049A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12415000B2 (en) | 2017-07-07 | 2025-09-16 | The Broad Institute, Inc. | CRISPR system based antiviral therapy |
| WO2019094955A1 (en) | 2017-11-13 | 2019-05-16 | The Broad Institute, Inc. | Methods and compositions for targeting developmental and oncogenic programs in h3k27m gliomas |
| EP3814519A1 (en) | 2018-06-26 | 2021-05-05 | The Broad Institute, Inc. | Crispr/cas and transposase based amplification compositions, systems and methods |
| US12402610B2 (en) | 2018-11-09 | 2025-09-02 | The Broad Institute, Inc. | Methods and compositions for modulating innate lymphoid cell pathogenic effectors |
| CN114981409A (zh) | 2019-09-03 | 2022-08-30 | 美洛德生物医药公司 | 用于基因组整合的方法和组合物 |
| WO2021146641A1 (en) | 2020-01-17 | 2021-07-22 | The Broad Institute, Inc. | Small type ii-d cas proteins and methods of use thereof |
| US20250283152A1 (en) * | 2021-02-09 | 2025-09-11 | Sherlock Biosciences, Inc. | Nucleic acid amplification using promoter primers |
| BR112023023642A2 (pt) | 2021-05-11 | 2024-01-30 | Myeloid Therapeutics Inc | Métodos e composições para integração genômica |
| WO2023283622A1 (en) | 2021-07-08 | 2023-01-12 | Montana State University | Crispr-based programmable rna editing |
| WO2023004391A2 (en) * | 2021-07-21 | 2023-01-26 | Montana State University | Nucleic acid detection using type iii crispr complex |
| KR102576803B1 (ko) * | 2022-10-14 | 2023-09-12 | 주식회사 풀무원 | CRISPR-Cas 기반의 리스테리아 모노사이토제네스 검출용 조성물 및 이를 이용한 리스테리아 모노사이토제네스 검출방법 |
| US12435357B2 (en) | 2022-12-22 | 2025-10-07 | Kanso Diagnostics Ltd. | Diagnostic device for detecting a target nucleic acid molecule in a biological sample |
| WO2024238563A2 (en) * | 2023-05-15 | 2024-11-21 | Vedabio, Inc. | Arrayed detection of target molecules via crispr cascade reactions |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2541765A1 (en) | 2003-10-10 | 2004-10-01 | Promega Corporation | Luciferase biosensor |
| US9193959B2 (en) | 2010-04-16 | 2015-11-24 | Roche Diagnostics Operations, Inc. | T7 RNA polymerase variants with enhanced thermostability |
| AU2013293270B2 (en) | 2012-07-25 | 2018-08-16 | Massachusetts Institute Of Technology | Inducible DNA binding proteins and genome perturbation tools and applications thereof |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| WO2014093655A2 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains |
| EP2931899A1 (en) | 2012-12-12 | 2015-10-21 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof |
| US20140186843A1 (en) | 2012-12-12 | 2014-07-03 | Massachusetts Institute Of Technology | Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof |
| CN113355357B (zh) | 2012-12-12 | 2024-12-03 | 布罗德研究所有限公司 | 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化 |
| IL239344B2 (en) | 2012-12-12 | 2024-06-01 | Broad Inst Inc | Systems engineering, methods and optimal guiding components for sequence manipulation |
| EP2840140B2 (en) | 2012-12-12 | 2023-02-22 | The Broad Institute, Inc. | Crispr-Cas based method for mutation of prokaryotic cells |
| US20140310830A1 (en) | 2012-12-12 | 2014-10-16 | Feng Zhang | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes |
| EP3031921B1 (en) | 2012-12-12 | 2025-03-12 | The Broad Institute, Inc. | Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications |
| WO2014093709A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof |
| US11332719B2 (en) | 2013-03-15 | 2022-05-17 | The Broad Institute, Inc. | Recombinant virus and preparations thereof |
| EP3725885A1 (en) | 2013-06-17 | 2020-10-21 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof |
| MX374532B (es) | 2013-06-17 | 2025-03-06 | Broad Inst Inc | Suministro, uso y aplicaciones terapéuticas de los sistemas y composiciones crispr-cas, para actuar sobre trastornos y enfermedades utilizando componentes víricos. |
| WO2014204723A1 (en) | 2013-06-17 | 2014-12-24 | The Broad Institute Inc. | Oncogenic models based on delivery and use of the crispr-cas systems, vectors and compositions |
| RU2716420C2 (ru) | 2013-06-17 | 2020-03-11 | Те Брод Инститьют Инк. | Доставка и применение систем crispr-cas, векторов и композиций для целенаправленного воздействия и терапии в печени |
| CN105492611A (zh) | 2013-06-17 | 2016-04-13 | 布罗德研究所有限公司 | 用于序列操纵的优化的crispr-cas双切口酶系统、方法以及组合物 |
| CN105683379A (zh) | 2013-06-17 | 2016-06-15 | 布罗德研究所有限公司 | 用于对有丝分裂后细胞的疾病和障碍进行靶向和建模的系统、方法和组合物的递送、工程化和优化 |
| WO2014204724A1 (en) | 2013-06-17 | 2014-12-24 | The Broad Institute Inc. | Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation |
| EP3058091B1 (en) | 2013-10-18 | 2020-03-25 | The Broad Institute, Inc. | Spatial and cellular mapping of biomolecules in situ by high-throughput sequencing |
| CN106459995B (zh) | 2013-11-07 | 2020-02-21 | 爱迪塔斯医药有限公司 | 使用统治型gRNA的CRISPR相关方法和组合物 |
| JP6712948B2 (ja) | 2013-12-12 | 2020-06-24 | ザ・ブロード・インスティテュート・インコーポレイテッド | 組成物、及びヌクレオチドリピート障害におけるｃｒｉｓｐｒ−ｃａｓ系の使用方法 |
| WO2015089427A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Crispr-cas systems and methods for altering expression of gene products, structural information and inducible modular cas enzymes |
| EP3470089A1 (en) | 2013-12-12 | 2019-04-17 | The Broad Institute Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components |
| EP3080259B1 (en) | 2013-12-12 | 2023-02-01 | The Broad Institute, Inc. | Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation |
| WO2015089364A1 (en) | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Crystal structure of a crispr-cas system, and uses thereof |
| JP6793547B2 (ja) | 2013-12-12 | 2020-12-02 | ザ・ブロード・インスティテュート・インコーポレイテッド | 最適化機能ＣＲＩＳＰＲ−Ｃａｓ系による配列操作のための系、方法および組成物 |
| JP7103750B2 (ja) | 2013-12-12 | 2022-07-20 | ザ・ブロード・インスティテュート・インコーポレイテッド | ゲノム編集のためのＣＲＩＳＰＲ－Ｃａｓ系及び組成物の送達、使用及び治療適用 |
| SG10201804975PA (en) | 2013-12-12 | 2018-07-30 | Broad Inst Inc | Delivery, Use and Therapeutic Applications of the Crispr-Cas Systems and Compositions for HBV and Viral Diseases and Disorders |
| CN105463066B (zh) * | 2014-09-04 | 2019-05-17 | 中国科学院北京基因组研究所 | 一种dna扩增方法 |
| EP3889260A1 (en) | 2014-12-12 | 2021-10-06 | The Broad Institute, Inc. | Protected guide rnas (pgrnas) |
| WO2016094872A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Dead guides for crispr transcription factors |
| WO2016094874A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Escorted and functionalized guides for crispr-cas systems |
| DK3234187T3 (da) * | 2014-12-15 | 2021-05-25 | Illumina Inc | Fremgangsmåde til enkeltmolekyleanbringelse på et substrat |
| CA2970370A1 (en) | 2014-12-24 | 2016-06-30 | Massachusetts Institute Of Technology | Crispr having or associated with destabilization domains |
| US10968536B2 (en) * | 2015-02-25 | 2021-04-06 | Jumpcode Genomics, Inc. | Methods and compositions for sequencing |
| WO2016180379A1 (es) * | 2015-05-14 | 2016-11-17 | Universidad De Los Andes | Nuevo transposón que promueve la expresión funcional de genes en adns episomales y un método para aumentar la transcripción de adn en análisis funcionales de librerías metagenómicas |
| MX2018000729A (es) * | 2015-07-17 | 2018-09-06 | Harvard College | Métodos para amplificar las secuencias de ácido nucleico. |
| AU2017257274B2 (en) | 2016-04-19 | 2023-07-13 | Massachusetts Institute Of Technology | Novel CRISPR enzymes and systems |
| EP3445853A1 (en) * | 2016-04-19 | 2019-02-27 | The Broad Institute, Inc. | Cpf1 complexes with reduced indel activity |
| CN105861552B (zh) * | 2016-04-25 | 2019-10-11 | 西北农林科技大学 | 一种T7 RNA聚合酶介导的CRISPR/Cas9基因编辑系统的构建方法 |
| CN105950639A (zh) | 2016-05-04 | 2016-09-21 | 广州美格生物科技有限公司 | 金黄色葡萄球菌CRISPR/Cas9系统的制备及其在构建小鼠模型中的应用 |
| CN109642231A (zh) | 2016-06-17 | 2019-04-16 | 博德研究所 | Vi型crispr直向同源物和系统 |
| CN110506128A (zh) * | 2016-12-09 | 2019-11-26 | 博德研究所 | 基于crispr效应系统的诊断 |
| KR20190140918A (ko) | 2017-03-15 | 2019-12-20 | 더 브로드 인스티튜트, 인코퍼레이티드 | 바이러스 검출을 위한 crispr 이펙터 시스템 기반 진단 |
| US10400235B2 (en) * | 2017-05-26 | 2019-09-03 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
| CN107937328B (zh) * | 2017-11-30 | 2018-09-14 | 中央民族大学 | 基于细胞的比较器及应用与细胞计算机 |
| EP3814519A1 (en) | 2018-06-26 | 2021-05-05 | The Broad Institute, Inc. | Crispr/cas and transposase based amplification compositions, systems and methods |
-
2019
- 2019-06-26 EP EP19739830.8A patent/EP3814519A1/en not_active Withdrawn
- 2019-06-26 BR BR112020025319-7A patent/BR112020025319A2/pt not_active IP Right Cessation
- 2019-06-26 MX MX2020013778A patent/MX2020013778A/es unknown
- 2019-06-26 KR KR1020217001470A patent/KR20210024009A/ko not_active Withdrawn
- 2019-06-26 AU AU2019294690A patent/AU2019294690A1/en not_active Abandoned
- 2019-06-26 US US17/054,428 patent/US12559786B2/en active Active
- 2019-06-26 JP JP2020572532A patent/JP2021528975A/ja active Pending
- 2019-06-26 CA CA3101066A patent/CA3101066A1/en active Pending
- 2019-06-26 CN CN201980043102.2A patent/CN112368396A/zh active Pending
- 2019-06-26 WO PCT/US2019/039195 patent/WO2020006049A1/en not_active Ceased
- 2019-06-26 SG SG11202011240YA patent/SG11202011240YA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN112368396A (zh) | 2021-02-12 |
| MX2020013778A (es) | 2021-05-27 |
| US20210147915A1 (en) | 2021-05-20 |
| WO2020006049A1 (en) | 2020-01-02 |
| AU2019294690A1 (en) | 2020-12-03 |
| BR112020025319A2 (pt) | 2021-03-09 |
| JP2021528975A (ja) | 2021-10-28 |
| US12559786B2 (en) | 2026-02-24 |
| KR20210024009A (ko) | 2021-03-04 |
| EP3814519A1 (en) | 2021-05-05 |
| CA3101066A1 (en) | 2020-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202011240YA (en) | Crispr/cas and transposase based amplification compositions, systems and methods | |
| IL278963A (en) | Dual NICKASE-based CRISPR amplification preparations, systems and methods | |
| IL281159A (en) | New CRISPR enzymes and systems | |
| SG11202106263XA (en) | Amplification methods and systems for merfish and other applications | |
| SG11202104347UA (en) | Novel crispr/cas12f enzyme and system | |
| IL280134A (en) | Anti-CD112R preparations and methods | |
| SG11201913852RA (en) | Target-specific crispr mutant | |
| IL271193A (en) | Preparations and methods for internalizing enzymes | |
| IL268829A (en) | CRISPR CAS9 engineering secreted vaccine | |
| HK1254843B (zh) | 包含细菌菌株的组合物 | |
| WO2016103233A3 (en) | Systems and methods for genome modification and regulation | |
| EP3601339A4 (en) | DNA ANTIGEN EXCHANGE AND AMPLIFICATION | |
| WO2016044463A3 (en) | Mk2 inhibitors and uses thereof | |
| MX2017007645A (es) | Composiciones inhibidoras de nitrificacion y metodos para preparar las mismas. | |
| WO2017214240A3 (en) | Cleaning compositions having an enzyme system | |
| SG11202104448WA (en) | Compositions and methods | |
| GB2576614B (en) | Compositions, uses and methods | |
| IL279059A (en) | Methods and preparations for killing spores | |
| GB201817444D0 (en) | Methods and compositions | |
| GB201804163D0 (en) | Uses, compositions and methods | |
| GB201804092D0 (en) | Methods and compositions | |
| ZA202104192B (en) | Mmpl3 inhibitors, compositions and uses thereof | |
| IL257796B (en) | Soluble and solid pyric pyrophosphate formulations, kits, and methods used therein | |
| HK40047006A (en) | Crispr/cas and transposase based amplification compositions, systems and methods | |
| HK40042171A (en) | Crispr double nickase based amplification compositions, systems, and methods |